UPDATE: Biogen Idec (BIIB) wins FDA approval for MS pill

March 27, 2013 3:34 PM EDT Send to a Friend
(Updated - March 27, 2013 3:35 PM EDT)

Biogen Idec, Inc. (NASDAQ: BIIB) wins FDA approval for MS pill.
This article: 384 words
-->

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login